Elutia(ELUT) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro Antibiotic-Eluting BioEnvelope in 2025 Over 100 EluPro VAC Submissions and 19% SimpliDerm Growth Drive Momentum into 2025 SILVER SPRING, Md., November 14, 2024 — Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix products, today provided a business update and financial results for the third quarter ended September 30, 2024. Business Highlights: · First Commercial Use ...